|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
1 |
c.(?_-227)_67+?del |
Exon 1-2del |
- |
0.997329073 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
13.338828 |
1.1664 |
- |
- |
- |
15.55840898 |
Deletion spans exons 1 and 2, including the translation initiation methionine |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
1 |
c.-39-36C>G |
IVS1-36C>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
1.7036 |
1.06 |
- |
- |
- |
1.805816 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
1 |
c.-39-26G>A |
IVS1-26G>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.9939069 |
- |
- |
- |
- |
0.9939069 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
1 |
c.-39-14C>T |
IVS1-14C>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.580175601 |
1.024615386 |
- |
0.594456847 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
1 |
c.-39-12_-39-10del |
IVS1-12del3 |
- |
0.639466064 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.34 |
- |
1.06 |
2.255368045 |
1.440167753 |
- |
3.44299483 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
1 |
c.-39-5del |
IVS1-5delT |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
0.917713029 |
1.129287087 |
- |
1.036361473 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.-34T>C |
5'UTR195T>C |
- |
0.007950928 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.365088485 |
1.075678821 |
- |
0.392717951 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.-15A>C |
5'UTR214A>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.935148591 |
2.074083157 |
- |
1.939575942 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.-14T>C |
5'UTR215T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
1.623716074 |
1.049836689 |
- |
1.704636706 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.-12T>C |
5'UTR217T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.789804038 |
1.049836689 |
- |
0.829165256 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.-9T>C |
5'UTR220T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
3.650000079 |
- |
0.114977673 |
1.405569136 |
- |
0.58987311 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.2T>G |
230T>G |
p.M1R |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
- |
0.72 |
- |
- |
- |
0.72 |
Translation initiation methionine site |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.3del |
231delG |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
- |
- |
1.687482976 |
1.024615386 |
- |
1.72902102 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.3G>A |
231G>A |
p.M1I |
0.999735509 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.96 |
67.62110446 |
2.172628915 |
- |
1.072 |
- |
157.4934876 |
Translation initiation methionine site |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
?/? |
2 |
c.3G>A |
231G>A |
p.M1I |
0.981 |
4 - Likely pathogenic |
Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
- |
0.02 |
0.00 |
0.96 |
2.0 |
- |
- |
1.07 |
- |
2.14 |
Translation initiation methionine site |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.5C>T |
233C>T |
p.P2L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.653337939 |
1.024615386 |
- |
0.669420104 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.26C>T |
254C>T |
p.P9L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.827519458 |
1.024615386 |
- |
1.872504555 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.34T>G |
262T>G |
p.F12V |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.845804261 |
1.024615386 |
- |
0.866624059 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.52C>T |
280C>T |
p.R18C |
0.012984563 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
0.0366 |
0.88 |
- |
- |
- |
0.032208 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.66A>T |
294A>T |
p.A22A |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
- |
- |
0.9357424 |
1.024615386 |
- |
0.95877606 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+1del |
IVS2+1delG |
- |
0.835013418 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
0.14321728 |
- |
1.066689585 |
1.024615386 |
- |
0.156528834 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+1G>A |
IVS2+1G>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
2.247537589 |
1.11453872 |
0.414387178 |
1.244651749 |
- |
1.291981476 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+1G>T |
IVS2+1G>T |
- |
0.995728813 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
3.906318754 |
1.191016 |
1.476165189 |
1.049836689 |
- |
7.210111485 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+2T>C |
IVS2+2T>C |
- |
0.985499065 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
1.861252833 |
1.129287087 |
- |
2.101888789 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+3A>G |
IVS2+3A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
0.89 |
- |
- |
- |
0.89 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
|
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
2 |
c.67+4T>C |
IVS2+4T>C |
- |
0.10793887 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
2.699677429 |
1.075678821 |
- |
2.903985834 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+62T>G |
IVS2+62T>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.671616 |
- |
- |
- |
0.671616 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
2 |
c.67+82C>G |
IVS2+82C>G |
- |
7.8219E-136 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
1.46786E-18 |
- |
- |
2.6111E-116 |
3.8327e-134 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.73G>A |
301G>A |
p.G25R |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
0.516123134 |
1.024615386 |
- |
0.528827704 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.116C>T |
344C>T |
p.A39V |
0.0022093 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.02 |
- |
- |
0.098439155 |
1.102157073 |
- |
0.108495411 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
?/? |
3 |
c.125A>G |
353A>G |
p.Y42C |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Goldgar et al., AJHG 75: 535-544, 2004. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.00000067 |
- |
- |
8.9E-11 |
- |
5.96300E-17 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.164A>G |
392A>G |
p.N55S |
0.051552781 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.47601001 |
1.075678821 |
- |
2.663391529 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.189A>C |
417A>C |
p.K63N |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.491981128 |
1.024615386 |
- |
0.504091433 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.221T>C |
449T>C |
p.L74P |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.31833358 |
1.024615386 |
- |
1.35078487 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.240A>G |
468A>G |
p.I80M |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.666795446 |
1.102157073 |
- |
0.734913316 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.241T>G |
469T>G |
p.F81V |
0.006632596 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.319307311 |
1.024615386 |
- |
0.327167184 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.263T>G |
491T>G |
p.L88R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.538217837 |
1.102157073 |
- |
1.695357668 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.277T>C |
505T>C |
p.S93P |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.31833358 |
1.024615386 |
- |
1.35078487 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
?/? |
3 |
c.316+5G>A |
IVS3+5G>A |
- |
0.744 |
3 - Uncertain |
Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
- |
0.34 |
0.00 |
0.34 |
3.16 |
- |
1.51 |
1.18 |
- |
5.64 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
3 |
c.317-10A>G |
IVS3-10A>G |
- |
0.015161009 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.311636266 |
1.18556701 |
- |
0.369465677 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.322A>C |
550A>C |
p.N108H |
0.001214835 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.040389394 |
1.475618079 |
- |
0.059599319 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.341A>G |
569A>G |
p.H114R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.561752801 |
1.049836689 |
- |
0.5897487 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.343A>G |
571A>G |
p.K115E |
0.005959537 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.266539172 |
1.102157073 |
- |
0.293768033 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.352C>T |
580C>T |
p.R118C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.491981128 |
1.049836689 |
- |
0.516499838 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.353G>A |
581G>A |
p.R118H |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.0104 |
2.007534 |
0.508026915 |
1.075678821 |
- |
1.108474193 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.379G>T |
607G>T |
p.A127S |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.508026915 |
1.049836689 |
- |
0.533345294 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.425G>A |
653G>A |
p.S142N |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
1.5539 |
0.89 |
- |
- |
- |
1.382971 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.425G>T |
653G>T |
p.S142I |
0.920515566 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
0.3187769 |
1.1236 |
- |
- |
- |
0.358177725 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.425+33A>G |
IVS4+33A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.7832 |
- |
1.14 |
- |
0.892848 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.426-22G>T |
IVS4-22G>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
- |
1.024 |
- |
1.024 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
|
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
4 |
c.426-17G>T |
IVS4-17G>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
1.042930986 |
1.024615386 |
- |
1.068603135 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.426-12_426-8del |
IVS4-12del5 |
- |
0.065461868 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.34 |
0.2856 |
0.4761 |
- |
- |
- |
0.13597416 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
4 |
c.426-12G>A |
IVS4-12G>A |
- |
0.168552141 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.374837062 |
1.049836689 |
- |
0.3935177 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.433_435del |
661del3 |
- |
0.09772304 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
4.061473146 |
1.306681054 |
- |
5.307050013 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.437T>C |
665T>C |
p.L146P |
0.009010061 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.434804153 |
1.024615386 |
- |
0.445507025 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.440A>G |
668A>G |
p.Q147R |
0.000602552 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.2789 |
1.1449 |
0.177284374 |
0.113809233 |
- |
0.02954283 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.440A>T |
668A>T |
p.Q147L |
0.009494194 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.5353 |
1.06 |
0.76950495 |
1.075678821 |
- |
0.469674676 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.442T>C |
670T>C |
p.C148R |
0.044447888 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
1.8939 |
1.146341562 |
1.049836689 |
- |
2.27925454 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.455C>A |
683C>A |
p.T152K |
0.052514452 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.650583274 |
1.024615386 |
- |
2.715828403 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.464G>T |
692G>T |
p.R155I |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.899 |
- |
- |
- |
- |
1.899 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.467A>G |
695A>G |
p.D156G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.295199976 |
- |
1.146341562 |
1.62636286 |
- |
0.550361194 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.473C>T |
701C>T |
p.S158L |
0.537103686 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
- |
- |
1.766162686 |
1.275289324 |
- |
2.252368419 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.475+1G>T |
IVS5+1G>T |
- |
0.998543659 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1.8997 |
- |
9.189283103 |
1.214750213 |
- |
21.20575004 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.475+4del |
IVS5+4delT |
- |
0.779887134 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.34 |
- |
- |
6.393942527 |
1.075678821 |
- |
6.87782856 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.476-9dup |
IVS5-9insT |
- |
0.098973992 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
2.511153476 |
1.049836689 |
- |
2.63630105 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.476-9del |
IVS5-9delT |
- |
0.100618519 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
2.557546115 |
1.049836689 |
- |
2.685005744 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.476-8A>C |
IVS5-8A>C |
- |
0.019555738 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.467198739 |
1.024615386 |
- |
0.478699017 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.476-3C>T |
IVS5-3C>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.801601969 |
1.075678821 |
- |
0.862266261 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
5 |
c.476-1G>A |
IVS5-1G>A |
- |
0.988886359 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1.2313 |
- |
2.181297031 |
1.024615386 |
- |
2.751943801 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
?/? |
6 |
c.476-2A>G |
IVS5-2A>G |
- |
0.999 |
5 - Definitely pathogenic |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
18.20 |
1.17 |
- |
21.38 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.483T>G |
711T>G |
p.C161W |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.3 |
- |
1.06 |
- |
- |
- |
1.06 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.502C>G |
730C>G |
p.P168A |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.491981128 |
1.024615386 |
- |
0.504091433 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.506A>G |
734A>G |
p.K169R |
0.038818567 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.3 |
- |
1.07 |
0.963157845 |
0.09143862 |
- |
0.094234712 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516G>A |
744G>A |
p.K172K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
- |
- |
0.879637931 |
1.049836689 |
- |
0.923476173 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516G>T |
744G>T |
p.K172N |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
- |
- |
1.662621915 |
1.049836689 |
- |
1.745481485 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
|
|
DNA change |
|
| |
|
|
|
|
Key Observational Reference |
|
| |
|
Missense analysis Prior P |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
6 |
c.516+1G>T |
IVS6+1G>T |
- |
0.810717384 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
0.270340093 |
0.49000196 |
- |
- |
- |
0.132467176 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516+7A>G |
IVS6+7A>G |
- |
0.198808006 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
11.86676865 |
1.024615386 |
- |
12.15887374 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516+10C>T |
IVS6+10C>T |
- |
0.044780252 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
2.241911433 |
1.024615386 |
- |
2.297096948 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516+14C>T |
IVS6+14C>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.6953 |
1.1236 |
- |
- |
- |
0.78123908 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.516+18T>C |
IVS6+18T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
- |
1.024 |
- |
1.024 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.517-16T>C |
IVS6-16T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.823959877 |
1.024615386 |
- |
0.844241967 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.517-11T>C |
IVS6-11T>C |
- |
0.011391939 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.244895265 |
1.129287087 |
- |
0.276557061 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
6 |
c.517-2A>G |
IVS6-2A>G |
- |
0.999417675 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
3.496606341 |
3.821067378 |
3.115235012 |
1.275289324 |
- |
53.08000753 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.559G>A |
787G>A |
p.E187K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.19104548 |
1.049836689 |
- |
1.250403243 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.581G>C |
809G>C |
p.W194S |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.212664236 |
1.024615386 |
- |
1.242514434 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.631G>C |
859G>C |
p.V211L |
- |
- |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
- |
- |
0.472727355 |
1.157084926 |
- |
0.546985697 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.631+2T>G |
IVS7+2T>G |
- |
0.998311237 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
22.51465722 |
0.81204768 |
- |
- |
- |
18.28297516 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.631+7A>G |
IVS7+7A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.9866 |
- |
- |
- |
- |
0.9866 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.631+25C>T |
IVS7+25C>T |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
1.0157 |
0.9328 |
- |
- |
- |
0.94744496 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-69T>C |
IVS7-69T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.6589 |
1.6324 |
- |
- |
- |
1.07558836 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-18_632-17del |
IVS7-18delTA |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.34 |
- |
- |
0.95233238 |
1.049836689 |
- |
0.999793472 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
?/? |
8 |
c.632-16A>C |
IVS7-16A>C |
- |
0.011 |
2 - Likely not pathogenic or of little clinical significance |
Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
- |
0.04 |
0.00 |
0.04 |
- |
- |
0.22 |
1.20 |
- |
0.27 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-10del |
IVS7-10delT |
- |
0.013448635 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
0.319307311 |
1.024615386 |
- |
0.327167184 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-9A>G |
IVS7-9A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.845804261 |
1.049836689 |
- |
0.887956344 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-3C>A |
IVS7-3C>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.494226238 |
1.049836689 |
- |
0.518856837 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-3C>G |
IVS7-3C>G |
- |
0.991879136 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
3.598191516 |
1.049836689 |
- |
3.777513466 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-2A>G |
IVS7-2A>G |
- |
0.998675258 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
152.3272305 |
0.790591842 |
0.184412773 |
1.049836689 |
- |
23.31538652 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-1G>A |
IVS7-1G>A |
- |
0.999853152 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
95.32615552 |
2.20904496 |
- |
- |
- |
210.5797634 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
7 |
c.632-16A>C |
IVS7-16A>C |
- |
0.011116127 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.222853939 |
1.210595757 |
- |
0.269786033 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |
- |
8 |
c.663T>G |
891T>G |
p.F221L |
0.06609215 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
3.223734841 |
1.075678821 |
- |
3.467703294 |
- |
- |
United States:Salt Lake City |
DNA |
SEQ |
- |
1 |